Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Typical treatment plans involve: Daily BPC-157 at 250-500 mcg via subcutaneous injection, usually in the morning
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
Sodium Hyaluronate
In case of an allergic response, consult a healthcare professional immediately
US$ 28.87
US$ 20.87
US$ 25.33
US$ 21.28
US$ 27.97
US$ 24.29
US$ 28.13
